Fasting and Cancer: Autophagy, Apoptosis, and the Evidence for Fasting-Mimicking Diets

Written by Adam Maggio | Medically reviewed by Dr. Sarah Chen, PharmD, BCPS

Fasting, once primarily associated with religious or cultural practices, has emerged as a compelling intervention in the fields of longevity and oncology.

# Fasting and Cancer: Autophagy, Apoptosis, and the Evidence for Fasting-Mimicking Diets

Fasting, once primarily associated with religious or cultural practices, has emerged as a compelling intervention in the fields of longevity and oncology. Beyond its well-known metabolic benefits, periodic fasting and fasting-mimicking diets (FMDs) are gaining traction for their potential to enhance cancer treatment efficacy, reduce side effects, and potentially lower cancer risk. The underlying mechanisms involve fundamental cellular processes such as autophagy and apoptosis, which are critical for cellular health and tumor suppression. For practitioners, understanding these mechanisms and the evidence for FMDs is essential for integrating these strategies into comprehensive patient care.

Cellular Mechanisms: Autophagy and Apoptosis

Fasting triggers a profound shift in cellular metabolism and stress responses, activating pathways that are highly relevant to cancer biology:

1. Autophagy: Cellular Housekeeping and Tumor Suppression

Autophagy (from Greek, 'self-eating') is a conserved cellular process responsible for the degradation and recycling of damaged organelles, misfolded proteins, and other cellular debris. During periods of nutrient deprivation, cells upregulate autophagy to generate energy and building blocks from internal sources. This process is crucial for maintaining cellular homeostasis and preventing the accumulation of molecular damage that can lead to oncogenesis [1].

In the context of cancer, autophagy plays a dual role: it can act as a tumor suppressor by removing damaged components and preventing DNA damage, but it can also support the survival of established tumors under stress conditions. However, in the context of periodic fasting, the acute induction of autophagy is generally considered beneficial, promoting cellular resilience and potentially clearing pre-cancerous cells.

2. Apoptosis: Programmed Cell Death

Apoptosis is a form of programmed cell death that is essential for normal development and tissue homeostasis. It serves as a critical defense mechanism against cancer by eliminating cells that are damaged, infected, or have undergone oncogenic transformation. Fasting can enhance the sensitivity of cancer cells to apoptosis while protecting healthy cells, a phenomenon known as differential stress sensitization (DSS) [2].

Fasting's Impact on Cancer Pathways

Beyond autophagy and apoptosis, fasting influences several key pathways relevant to cancer:

Reduced Growth Factor Signaling: Fasting significantly lowers circulating levels of glucose, insulin, and Insulin-like Growth Factor 1 (IGF-1). These growth factors are potent mitogens that promote cancer cell proliferation and survival. By reducing their levels, fasting creates an unfavorable metabolic environment for tumor growth [3].

Increased Stress Resistance in Healthy Cells: Fasting induces a state of mild stress in healthy cells, prompting them to activate protective mechanisms and become more resilient to subsequent stressors, including chemotherapy and radiation. Cancer cells, often metabolically inflexible and already under stress, do not mount the same protective response, making them more vulnerable [2].

Modulation of Immune Function: Fasting can promote the regeneration of the immune system, including the clearance of old or damaged immune cells and the generation of new ones, potentially enhancing anti-tumor immunity [4].

Chemosensitization and Radiosensitization: Preclinical and some clinical studies suggest that FMDs, when administered around chemotherapy or radiation cycles, can make cancer cells more susceptible to treatment while protecting healthy cells from damage. This differential effect can improve treatment efficacy and reduce side effects [6].

Reduced Side Effects: Patients undergoing chemotherapy often experience severe side effects. FMDs have shown promise in mitigating these, including reducing fatigue, nausea, and myelosuppression [7].

Potential for Cancer Prevention and Management: While more research is needed, periodic FMDs may contribute to cancer prevention by reducing growth factor signaling, enhancing autophagy, and improving metabolic health. In established cancers, FMDs might slow progression or improve response to standard therapies, though this should always be done under strict medical guidance.

Practical Takeaways for Practitioners

Integrating fasting strategies into oncology and longevity protocols requires careful consideration:

Patient Selection: FMDs are not suitable for all patients, especially those with significant weight loss, cachexia, or certain medical conditions. Thorough assessment is essential.

Medical Supervision: All fasting interventions, particularly in cancer patients, should be conducted under strict medical supervision by practitioners knowledgeable in the field.

Timing: For cancer patients, the timing of FMDs relative to chemotherapy or radiation cycles is critical and should be guided by specific protocols.

Nutritional Support: Ensure adequate hydration and electrolyte balance during FMDs. Post-fast refeeding should be carefully managed.

Fasting and FMDs represent powerful tools in the fight against cancer and the pursuit of longevity, leveraging ancient wisdom with modern scientific understanding. When applied judiciously and under expert guidance, they offer a promising adjunct to conventional therapies and a proactive strategy for health optimization.